乙二胺四乙酸置于phosphorus(III) Oxide,甲烷磺酸体系中,化学反应 2.0H,以94.5%的收率获得乙二胺四亚甲基膦酸 参考文献: Method For The Synthesis Of Alpha-Aminoalkylenephosphonic Acid[fr] Procédé De Synthèse D'Acide Alpha-Aminoalkylènephosphonique 标题: Method For The Synthesis Of Alpha-Aminoalkylenephosphonic Acid[fr] Procédé De Synthèse D'Acide Alpha-Aminoalkylènephosphonique 摘要:本发明涉及一种合成α-氨基烯基膦酸或其膦酸酯的新方法,包括以下步骤:通过混合含有一个p原子在氧化态(+111)和另一个p原子在氧化态(+111)或(+v)的p-O-P酸酐基团的化合物,氨基烷基羧酸和酸催化剂来形成反应混合物,其中所述反应混合物中α-氨基烯基羧酸与p-O-P酸酐基团的当量比至少为0.2,并从反应混合物中回收所得的α-氨基烯基膦酸化合物或其酯.
专利号:US-10280189-B2 优先权日:2012-07-17 标题:Method for the synthesis of aminoalkylenephosphonic acid 发明人:BURCK SEBASTIAN; LECLERCQ CEDRIC NICOLAS; NOTTE PATRICK 权利人:MONSANTO TECHNOLOGY LLC 摘要:A method for the synthesis of an aminoalkylenephosphonic acid or its phosphonate esters including the following steps: a) forming, in the presence of an aldehyde or ketone and an acid catalyst, a reaction mixture by mixing a compound having at least one HNR 1 R 2 moiety or a salt thereof, with a compound having one or more P—O—P anhydride moieties, the moieties having one P atom at the oxidation state (+III) and one P atom at the oxidation state (+III) or (+V), wherein the ratio of moles of aldehyde or ketone to N—H moieties is 1 or more and wherein the ratio of N—H moieties to P—O—P anhydride moieties is 0.3 or more, and b) recovering the resulting aminoalkylenephosphonic acid having compound or its phosphonate esters.
专利号:US-10464958-B2 优先权日:2012-07-17 标题 :Method for the synthesis of alpha-aminoalkylenephosphonic acid 发明人:NOTTE PATRICK; COGELS SAMUEL; BURCK SEBASTIAN 权利人:MONSANTO TECHNOLOGY LLC 摘要:The present invention is related to a new method for the synthesis of alpha-aminoalkylenephosphonic acid or its phosphonate esters comprising the steps of forming a reaction mixture by mixing a P—O—P anhydride moiety comprising compound, having one P-atom at the oxidation state (+III) and the other P-atom at the oxidation state (+III) or (+V), an aminoalkanecarboxylic acid and an acid catalyst, wherein said reaction mixture comprises an equivalent ratio of alpha-aminoalkylene carboxylic acid to P—O—P anhydride moieties of at least 0.2, and recovering the resulting alpha-aminoalkylene phosphonic acid compound or an ester thereof from the reaction mixture.
专利号:US-2022233673-A1 优先权日:2019-06-04 标 题:METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF 发明人:BILLET ANNE; SCHMIDT FRÉDÉRIC; JOHANNES LUDGER; SERVENT DENIS; MOURIER GILLES; TARTOUR ÉRIC; KAY MICHAEL; FULCHER JAMES M 权利人:INST CURIE; CENTRE NAT RECH SCIENT; INST NAT SANTE RECH MED; COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES CEA; APHP ASSIST PUBLIQUE HOPITAUX DE PARIS; UNIV PARIS; UNIV OF UTAH RESEARCH FOUDATION; UNIV UTAH RES FOUND 摘要:A method of producing a monomer of a Shiga toxin B-subunit (STxB) protein or of a variant thereof by peptide chemical synthesis, as well as to a method of producing a pentamer of the STxB protein or of the variant thereof. The methods are particularly advantageous as they overcome major issues typically observed in peptide chemical synthesis, including solubility and purity issues.
专利号:US-8147805-B2 优先权日:2005-01-05 标题:Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications 发明人:YANG DAVID; YU DONGFANG; CHANDA MITHU; AZHDARINIA ALI; OH CHANGSOK; KIM E EDMUND 权利人:YANG DAVID; YU DONGFANG; CHANDA MITHU; AZHDARINIA ALI; OH CHANGSOK; KIM E EDMUND; UNIV T EXAS SYSTEM BOARD OF REGENTS 摘要:Compositions and methods for dual imaging and for dual chemotherapy and radiotherapy are disclosed. More particularly, the invention concerns compounds comprising the structure X 1 —Y—X 2 , wherein Y comprises two or more carbohydrate residues covalently attached to one another, X 1 and X 2 are diagnostic or therapeutic moieties covalently attached to Y, provided that when Y does not comprise a glucosamine residue, X 1 and X 2 are diagnostic moieties. The present invention also concerns methods of synthesis of these compounds, application of such compounds for dual imaging and treatment of hyperproliferative disease, and kits for preparing a radiolabeled therapeutic or diagnostic compound.
专利号:US-4473708-A 优先权日:1981-07-09 标题:Preparation of ketozines using organoarsenic compounds 发明人:KURIYAMA YASUHISA; KAKUDA MINORU; NITOH SHOICHI 权利人:MITSUBISHI GAS CHEMICAL CO 摘要:A process for preparing a ketazine useful as an intermediate for the synthesis of hydrazine is disclosed. The process comprises reacting an aliphatic or aromatic ketone with ammonia and hydrogen peroxide in the presence of a catalyst of an arsenic compound to produce a corresponding ketazine.
专利号:US-2016293932-A1 优先权日:2015-03-30 标题 :Synthetic methods for transition metal coordination compounds 发明人:MOTALLEBI SHAHROKH; RISSET OLIVIA NATHALIE; WESSELLS COLIN DEANE 权利人:ALVEO ENERGY INC 摘要:A system and method for controlling particle morphology of transition metal coordination compounds (TMCC). Synthesis of TMCC using one of several chelating agents having carboxylate chemical groups. These carboxylate groups bind to copper during the synthesis of the CuHCF TMCC materials, resulting in controlled particle growth, rather than rapid formation of many small nanoparticles as is the case without any chelating agent present. The materials produced using chelating agents of these embodiments such as these are composed of larger particles, making them easier to process into battery electrodes via standard methods such as slurry mixing and coating. The resulting electrodes retain the good electrochemical cycling performance of the control material synthesized without a chelating agent.
摘要:S13 | EUCOSMETICS | Combined Inventory of Ingredients Employed in Cosmetic Products (2000) and Revised Inventory (2006) | DOI:10.5281/zenodo.2624118 参考文献:10.1097/01.mnm.0000126516.57329.07 摘要:Pedraza-López M, Ferro-Flores G, de Murphy CA, Tendilla JI, Villanueva-Sánchez O. Preparation of (166)Dy/(166)Ho-EDTMP: a potential in vivo generator system for bone marrow ablation. Nucl Med Commun. 2004 Jun;25(6):615–21. doi: 10.1097/01.mnm.0000126516.57329.07. 参考文献:10.1007/s10856-008-3426-1|10.1007/s10856-008-3470-x 摘要:Han YJ, Loo SCJ, Phung NT, Ong HT, Russell SJ, Peng K, Boey F, Ma J. Controlled size and morphology of EDTMP-doped hydroxyapatite nanoparticles as model for 153Samarium-EDTMP doping. Journal of Materials Science: Materials in Medicine. 2008 May 30;19(9):3161. doi: 10.1007/s10856-008-3470-x. 摘要:Bayouth JE, Macey DJ, Kasi LP, Fossella FV. Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases. J Nucl Med. 1994 Jan;35(1):63–9. 摘要:Jiang CY, Zhu BL, Zhang YJ. [The value of Sm-153-EDTMP for treatment of metastatic bone pain and improving quality of life]. Zhonghua Zhong Liu Za Zhi. 1994 Mar;16(2):118–21.